SubsidieMeestersAutomatic vein wall disruption, triggering the body’s natural cellular healing response to close targeted veins curing Venous Leg Ulcers
EnVena is a groundbreaking device designed to mimic the body's healing response, providing effective treatment for venous leg ulcers and addressing the limitations of current compression bandaging.
Projectdetails
Introduction
Chronic venous disease is one of the most common diseases in the developed world, affecting up to 60% of adults over the age of 50. Chronic venous disease is the leading cause of venous leg ulcers, which are chronic open sores, usually on the inside of the leg that will not heal without specialist treatment.
Economic Impact
The total costs associated with managing venous disease patients across Europe and the US is 33.4 billion per year, representing 2.5% of total healthcare expenditure.
Current Treatment Challenges
Most patients are treated with ineffective compression bandaging, which does not treat the underlying cause and has an unacceptably high recurrence rate. These bandages are also sent to landfill, resulting in a high environmental impact.
Innovative Solution
EnVena is the world's first device to mimic the body's natural healing response to deliver an effective treatment to venous leg ulcer patients.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.497.614 |
| Totale projectbegroting | € 3.611.770 |
Tijdlijn
| Startdatum | 1-10-2022 |
| Einddatum | 30-9-2024 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- INVERA MEDICAL LIMITEDpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Minimally invasive suturing for vascular bore closure and heart defect repairNovelrad's NVCD closure device aims to minimize complications in large-bore vascular closures during cardiac surgeries through innovative micro-suturing technology, facilitating safer and faster procedures. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Commercialising a smart cardiac implant platform for the treatment of chronic cardiovascular diseaseAuriGen's platform aims to reduce chronic cardiac disease deaths and costs in Europe by providing advanced, multi-functional cardiac devices for effective, minimally invasive patient treatment. | EIC Accelerator | € 2.499.999 | 2023 | Details |
Antibacterial wound dressing based on advanced nanotechnology to improve the efficiency of wound careNanordica aims to revolutionize wound care with an advanced antibacterial dressing that significantly reduces infections, lowers healthcare costs, and improves patient outcomes. | EIC Accelerator | € 2.402.750 | 2023 | Details |
Clinical validation of the First Implantable Sensor System for Wireless detection of stent occlusion/ restenosisVesselSens is developing StentGuard, a smart device for early, non-invasive detection of restenosis in PAD patients to improve outcomes and reduce healthcare costs. | EIC Accelerator | € 2.500.000 | 2022 | Details |
Restoring a normal life and dignity for women and men suffering from severe Stress Urinary IncontinenceDeveloping UroActive™, a smart artificial urinary sphincter that offers a safe, convenient, and effective solution for severe urinary incontinence, minimizing side effects and restoring patient dignity. | EIC Accelerator | € 2.499.999 | 2023 | Details |
Minimally invasive suturing for vascular bore closure and heart defect repair
Novelrad's NVCD closure device aims to minimize complications in large-bore vascular closures during cardiac surgeries through innovative micro-suturing technology, facilitating safer and faster procedures.
Commercialising a smart cardiac implant platform for the treatment of chronic cardiovascular disease
AuriGen's platform aims to reduce chronic cardiac disease deaths and costs in Europe by providing advanced, multi-functional cardiac devices for effective, minimally invasive patient treatment.
Antibacterial wound dressing based on advanced nanotechnology to improve the efficiency of wound care
Nanordica aims to revolutionize wound care with an advanced antibacterial dressing that significantly reduces infections, lowers healthcare costs, and improves patient outcomes.
Clinical validation of the First Implantable Sensor System for Wireless detection of stent occlusion/ restenosis
VesselSens is developing StentGuard, a smart device for early, non-invasive detection of restenosis in PAD patients to improve outcomes and reduce healthcare costs.
Restoring a normal life and dignity for women and men suffering from severe Stress Urinary Incontinence
Developing UroActive™, a smart artificial urinary sphincter that offers a safe, convenient, and effective solution for severe urinary incontinence, minimizing side effects and restoring patient dignity.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
PEDRIE: Wondgenezing met koud plasma pad en koud plasma pulserDit project ontwikkelt een kosteneffectief, pijnloos systeem voor de behandeling van diabetische voetzweren met koud-plasmatechnologie, gericht op verbetering van genezing en verlaging van zorgkosten. | Mkb-innovati... | € 349.230 | 2016 | Details |
Viewpoint Medical: VENA vein viewerViewpoint Medical ontwikkelt een slimme, draagbare en betaalbare aderviewer om de succesratio van venipuncties bij patiënten met moeilijke veneuze toegang te verbeteren. | Mkb-innovati... | € 20.000 | 2020 | Details |
HADRIEHet HADRIE-project ontwikkelt een thuisgebruik versie van het PLASOMA koud plasma systeem om chronische wonden effectiever en op grotere schaal te behandelen. | Mkb-innovati... | € 332.640 | 2018 | Details |
A Paradigm Shift in Health Monitoring with Electrospun Enzymatic NeomaterialsWOUNDSENS aims to develop innovative wearable biosensors integrated into smart wound dressings to enhance chronic wound monitoring and improve patient quality of life. | EIC Pathfinder | € 2.934.318 | 2023 | Details |
NXGHet NXG-project ontwikkelt een gebruiksvriendelijk, contactloos systeem voor efficiënte wondmonitoring, waardoor patiënten meer regie krijgen en zorgkosten verlaagd worden. | Mkb-innovati... | € 116.419 | 2017 | Details |
PEDRIE: Wondgenezing met koud plasma pad en koud plasma pulser
Dit project ontwikkelt een kosteneffectief, pijnloos systeem voor de behandeling van diabetische voetzweren met koud-plasmatechnologie, gericht op verbetering van genezing en verlaging van zorgkosten.
Viewpoint Medical: VENA vein viewer
Viewpoint Medical ontwikkelt een slimme, draagbare en betaalbare aderviewer om de succesratio van venipuncties bij patiënten met moeilijke veneuze toegang te verbeteren.
HADRIE
Het HADRIE-project ontwikkelt een thuisgebruik versie van het PLASOMA koud plasma systeem om chronische wonden effectiever en op grotere schaal te behandelen.
A Paradigm Shift in Health Monitoring with Electrospun Enzymatic Neomaterials
WOUNDSENS aims to develop innovative wearable biosensors integrated into smart wound dressings to enhance chronic wound monitoring and improve patient quality of life.
NXG
Het NXG-project ontwikkelt een gebruiksvriendelijk, contactloos systeem voor efficiënte wondmonitoring, waardoor patiënten meer regie krijgen en zorgkosten verlaagd worden.